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Abridged abstract [1]
Background Pilonidal sinus arises in the hair follicles in the 
buttock cleft. The estimated incidence is 26 per 100,000, 
people, affecting men twice as often as women. These 
chronic discharging wounds cause pain and impact upon 
quality of life. Surgical strategies centre on excision of the 
sinus tracts followed by primary closure and healing by pri-
mary intention or leaving the wound open to heal by second-
ary intention. There is uncertainty as to whether open or 
closed surgical management is more efective.
Objectives To determine the relative efects of open com-
pared with closed surgical treatment for pilonidal sinus on 
the outcomes of time to healing, infection and recurrence 
rate.
Selection criteria All randomised controlled trials (RCTs) 
comparing open with closed surgical treatment for pilonidal 
sinus. Exclusion criteria were: nonᒧRCTs, children aged 
younger than 14 years and studies of pilonidal abscess.
Main results For this update, 8 additional trials were 
identiied giving a total of 26 included studies (n = 2530). 
Seventeen studies compared open wound healing with surgi-
cal closure. Healing times were faster after surgical closure 
compared with open healing. Surgical site infection (SSI) 
rates did not difer between treatments; recurrence rates were 
lower in open healing than with primary closure (RR 0.60, 
95% CI 0.42–0.87). Six studies compared surgical midline 
with ofᒧmidline closure. Healing times were faster after 
of midline closure (MD 5.4 days, 95% CI 2.3–8.5). SSI 
rates were higher after midline closure (RR 3.72, 95% CI 
1.86–7.42) and recurrence rates were higher after midline 
closure (Peto OR 4.54, 95% CI 2.30–8.96).
Authors’ conclusions No clear beneit was shown for 
open healing over surgical closure. A clear beneit was 
shown in favour of of midline rather than midline wound 
closure. When closure of pilonidal sinuses is the desired 
surgical option, ofᒧmidline closure should be the standard 
management.
This Cochrane review [1] supports a generally held view 
by pilonidal surgery experts that, when excision and closure 
is carried out, closure should avoid the midline if optimal 
outcomes are to be achieved. However, despite this evidence, 
primary midline closure is still commonly carried out [2]. 
In addition, subsequent consensus and guideline publica-
tions suggest excision of disease and leaving the wound 
open results in prolonged recovery compared with closure 
techniques [2, 3] and yet the ‘leave open’ technique is the 
most commonly performed operation in the UK and other 
European countries [2, 4].
Why should this be? Reasons are potentially twofold
– There is a lack of experience and/or skill or interest in 
dealing with pilonidal disease by most surgeons.
Simple excision with or without primary closure is easy 
and quick. Alternative techniques such as Karydakis, Bas-
com’s cleft closure and laps are more complicated and do 
not really fall into the remit particularly of a colorectal spe-
cialist. Operations for PSD may be delegated to juniors or 
the condition is just not of suicient interest to many sur-
geons to keep up to date with the literature or learn new 
techniques.
– The evidence is not believable.
There is some basis to this perception. The evidence 
on the whole for pilonidal disease surgery is poor, with 
the majority of publications being case series or non-ran-
domised comparative trials from single-centre institutions, 
with the inherent bias that such studies bring. Nearly 90% 
of over 250 published studies in the 10 years since the 
AL-Khamis review are of this type and arguably should 
be ignored when reaching any consensus. Even the data 
included in this Cochrane review have faults, and these 
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faults persist in subsequent and current reports. These 
faults include:
– Lack of a widely accepted and validated classifica-
tion system. Pilonidal disease can vary from a simple 
asymptomatic pit through to extensive disease with 
multiple midline pits and lateral extensions, sometimes 
accompanied by marked scarring and deformity from 
previous failed interventions. Unless there is an objec-
tive way that PSD can be stratiied on randomisation or 
assurance that the baseline of each group is the same, 
any randomised controlled trial will be at great risk of 
being invalid.
– Single-centre studies The studies included in this review 
were mainly single centre in design with procedures 
likely to have been performed by advocates and pioneers 
of the intervention. Of approximately 35 RCTs published 
on pilonidal sinus surgery since this review, over 90% are 
single centre. Techniques need to be generalisable and 
real-world outcomes can only be estimated in multicentre 
trials.
– Multiple interventions and comparators Pilonidal surgery 
is a classic example of a disease where there is no obvi-
ous gold-standard treatment. As a consequence, multiple 
interventions exist. There is even variation within the 
recognised techniques and standardisation is poor. Whilst 
this review has been able to group the trials into two 
general groups, allowing some useful practical conclu-
sions to be drawn (i.e. avoid the midline closure), the 
literature makes more deinitive guidance almost impos-
sible to achieve. In RCTs published since 2010, around 
16 diferent interventions are compared with around 14 
diferent controls. This makes meaningful meta-analysis 
extremely challenging and comparison of ‘apples with 
pears’ and, like all meta analyses, need to be interpreted 
with care [5]. Moreover, comparing obsolete with current 
best practice is unhelpful and a waste of resources. For 
instance, an RCT of a novel intervention is meaningless 
if the comparator is excision and primary midline clo-
sure or even leave open, interventions considered inferior 
by the pilonidal expert community. Around 2/3 of the 
studies with higher quality design performed in the last 
10 years use invalid comparators, and as such lose much 
of their power to inform practice.
– Lack of an adequate sample size Trial numbers for the 
most recent studies vary from 19 to 800, with a median 
of around 70 patients for each arm of a comparative trial. 
Many studies have no evidence of any sample size calcu-
lation and in others, the details are vague, such that 75% 
of these trials can be considered inadequately powered. 
Few account for dropout even though this is likely to 
be high given the young mainly male and often mobile 
population. Several studies suggest a 100% follow-up 
even up to 5 years which is astoundingly complete!
– Selection of inappropriate outcome measures The selec-
tion of an appropriate outcome measure is perhaps the 
main criticism of any current pilonidal research. Of the 
RCTs published since the 2010 Cochrane review most do 
not state a primary outcome. Of those that do, outcomes 
vary from operative time, wound healing, wound closure, 
infection rates, return to normal activities/work, quality 
of life and, of course, recurrence.
The Cochrane review details healing as one of the main 
outcomes. Even this supericially straightforward endpoint 
leaves many areas that need to be clariied that are not 
addressed on the whole in studies using it as a primary end-
point. These ambiguities include: when does healing occur? 
How was it assessed? Did the patients truly and accurately 
deine the day of healing? How did they know? Was there 
clinical assessment on a daily basis? The accuracy of such 
an outcome measure has to be questioned and methods to 
measure it more precisely developed. The same is true for 
recurrence, another commonly used primary outcome and 
reported in virtually every paper in the Cochrane review. Is 
recurrence persistent non-healing or development of new 
disease after clinical evidence of healing after the study pro-
cedure, or indeed both? How long is follow-up necessary 
before recurrence can be dismissed? Follow-up varied from 
6 months to more than 3 years in RCTs reported after 2010.
– Outcome measures not relevant to patients Pilonidal 
sinus disease occurs in young adults at an age where 
body image is more important than at other stages of 
life, when relationships are formed and attendance at 
study or work is crucial to progression in life. In this 
group, long-term healing may not be the thing they want 
to achieve at all costs, and especially not at the cost of 
disiguring scaring, packing or time away from normal 
activities. If one intervention can be done as an oice 
procedure under local anaesthetic with rapid recovery 
and minimal post-operative pain but a 25% chance of 
recurrence, do patients value that more than an opera-
tion that requires a general anaesthetic, a stay in hospital, 
a drain and weeks recovering and/or a potential need for 
regular nursing input for dressings but a recurrence rate 
of 1–2% (although the real-world recurrence rate may 
well be much higher)? For PSD in children, treatments 
avoiding time of school is probably paramount.
– Cost effectiveness rarely considered The Cochrane review 
correctly suggested that meaningful research should also 
consider cost efectiveness as an outcome. Some pro-
cedures that require intensive post-operative health care 
involvement (e.g. regular dressings or packing) will have 
signiicant healthcare staf and consumable costs in addi-
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tion to societal costs, including time of work, in a young, 
active working population. Increased equipment costs for 
interventions such as endoscopic pilonidal sinus treat-
ment (EpSiT) and laser therapy or consumable costs such 
as ibrin glue must be also be included in the cost efec-
tiveness calculations.
It is clear that we need better evidence on how best to 
treat this unpleasant condition that has a signiicant impact 
on the young lives of suferers. Future trials should address 
the deiciencies in design outlined above. A standardised 
and accepted classiication system should be developed to 
minimise bias, allow readers to know exactly what kind of 
disease the intervention was treating and facilitate com-
parison of trial with trial and secondary analysis of results. 
Trials should be multicentric (as suggested in the review) 
to maximise the chance of successful in trial treatments 
being generalisable. Multicentre trials will also take into 
account inter-surgeon variation in technique, although such 
trials should seek to standardise technique by consensus as 
part of their design. Comparison should be between front 
running interventions and comparison should not be made 
with redundant, if commonly used, techniques. Niche and 
novel interventions can still be explored but according to 
idea, development, exploration, assessment, long-term 
study (IDEAL) framework criteria [6]. Studies should ide-
ally include health economic assessment, which incorporates 
evaluation of cost to primary and secondary care and also, 
if possible, cost to society in terms of time of work and 
similar metrics. Finally, and probably most importantly, it 
is patients who sufer from pilonidal sinus disease, and it 
is them who all too frequently have to sufer a treatment 
that may be worse than the disease. More work is needed 
on what patients’ value in terms of outcomes rather than a 
focus on what the surgeon perceives to be the most appro-
priate outcome measure. We have not moved the evidence 
base forward in any meaningful way since the Al-Khamis 
Cochrane review in 2010. Pilonidal sinus disease has a sig-
niicant impact on quality of life in young people and it is 
for the patients that we should do better, designing modern 
robust trials to provide high-quality evidence to inform deci-
sion making. Ask yourself if you would want to have a large 
hole cut in your natal cleft, left to heal by secondary inten-
tion over months?: if it’s not suitable for you, it’s not suitable 
for patients with pilonidal sinus disease. Let’s provide the 
evidence we need to move us out of the dark ages.
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